ARROWHEAD PHARMACEUTICALS, INC. (ARWR) › Total AssetsARROWHEAD PHARMACEUTICALS, INC. (ARWR) — Total AssetsAnnual figures by period end, from SEC filings.2010-09-30: $12.35M2011-09-30: $15.89M2012-09-30: $16.53M2013-09-30: $37.33M2014-09-30: $182.82M2015-09-30: $132.27M2016-09-30: $128.18M2017-09-30: $104.02M2018-09-30: $111.61M2019-09-30: $349.85M2020-09-30: $522.50M2021-09-30: $710.15M2022-09-30: $691.94M2023-09-30: $765.55M2024-09-30: $1.14B2025-09-30: $1.39B$1.39B2010-09-30Total Assets (USD)2025-09-30Period endedTotal AssetsChange YoYSource filing2025-09-30$1.39B+21.5%2025-11-25Balance as of period end2024-09-30$1.14B+48.9%2025-11-25Balance as of period end2023-09-30$765.55M+10.6%2024-11-26Balance as of period end2022-09-30$691.94M-2.6%2023-11-29Balance as of period end2021-09-30$710.15M+35.9%2022-11-28Balance as of period end2020-09-30$522.50M+49.4%2021-11-22Balance as of period end2019-09-30$349.85M+213.5%2020-11-23Balance as of period end2018-09-30$111.61M+7.3%2019-11-25Balance as of period end2017-09-30$104.02M-18.8%2018-12-11Balance as of period end2016-09-30$128.18M-3.1%2017-12-12Balance as of period end2015-09-30$132.27M-27.7%2016-12-14Balance as of period end2014-09-30$182.82M+389.7%2015-12-14Balance as of period end2013-09-30$37.33M+125.9%2014-11-25Balance as of period end2012-09-30$16.53M+4.0%2013-12-18Balance as of period end2011-09-30$15.89M+28.6%2012-12-28Balance as of period end2010-09-30$12.35M—2011-12-20Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)